As of Oct 09
| -0.88 / -6.71%|
The 6 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 16.25, with a high estimate of 22.00 and a low estimate of 14.00. The median estimate represents a +32.87% increase from the last price of 12.23.
The current consensus among 6 polled investment analysts is to Buy stock in AngioDynamics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.